Immunomedics Highlights Clinical Pipeline for Solid Cancer, Lupus Therapy at R&D Day

By: via Benzinga
Immunomedics, Inc. (Nasdaq: IMMU), a biopharmaceutical company focused on the development of monoclonal antibody-based products for the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.